OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
December 02, 2011
Drug shortages, supply-chain security, generic-drug incursion, and flexible manufacturing models are some of the issues shaping the bio/pharma industry.
Packaging is indeed headed to be a lead sector in the Asian pharmaceutical environment, but certain challenges must first be overcome.
A Q&A with Deborah Tanner, executive vice-president and group president of R&D laboratories at Covance, on recent industry trends.
Readers react to the economic turmoil of the past year and look longingly forward to 2012.
November 02, 2011
Small drug companies with hopes of achieving $1 billion in sales can pursue various strategies.
Clamor mounts over compromised care and rising costs due to lack of crucial therapies.
Careful mixing during a product's distillation can help avert trouble from a strong concoction.
Researchers develop various catalytic approaches for improving yield, purity, stereoselectivity, and process conditions.
Biosimilar manufacturers need better expression systems and analytical tools to compete.
Russia is aiming to provide an alternative to China and India for drug manufacturing, including APIs.